drugset / Trial / NCT04100135
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
RandomizedParallel-groupSingle-blindTreatment
Summary
Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief
Timeline
- Start
- 2021-02-05
- Primary completion
- 2024-08-15
- Completion
- 2024-08-15
Outcome
Outcome not reported
Stopped (Enrollment): “Dissatisfactory enrollment rate with no safety concerns”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Clopidogrel | Small molecule | — | — |
| Background | Prasugrel | Small molecule | — | — |